Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > (-)-Baclofen

(-)-Baclofen

pharmaceutical raw materials
(-)-Baclofen structure

(-)-Baclofen 

structure
  • CAS No:

    69308-37-8

  • Formula:

    C10H12ClNO2

  • Chemical Name:

    (-)-Baclofen

  • Synonyms:

    Benzenepropanoic acid,β-(aminomethyl)-4-chloro-,(βR)-;Benzenepropanoic acid,β-(aminomethyl)-4-chloro-,(R)-;(βR)-β-(Aminomethyl)-4-chlorobenzenepropanoic acid;l-Baclofen;(-)-Baclofen;(R)-Baclofen;(R)-(-)-Baclofen;(R)-4-Amino-3-(4-chlorophenyl)butanoic acid;D-Baclofen;R-(-)-Baclofen;(R)-4-Amino-3-(4-chlorophenyl)butyric acid;Arbaclofen;STX 209;AGI 006;(R)-4-Amino-3-(4-chlorophenyl)butanoic acid;(3R)-4-Amino-3-(4-chlorophenyl)butanoic acid;2375745-79-0

  • Categories:

    Biochemical Engineering  >  Inhibitors

Description

(R)-Baclofen(STX209) is a selective GABAB receptor agonist. IC50 value:Target: GABAB receptorGABAB receptors are metabotropic receptors which produce slow inhibitory signals. By manipulating GABAB receptor activity using Baclofen, a variety of functions are studied including synaptic transmissions and antinociception events.


Arbaclofen, or STX209, is the R-enantiomer of baclofen. It is believed to be a selective gamma-amino butyric acid type B receptor agonist, and has been investigated as a treatment for autism spectrum disorder and fragile X syndrome in randomized, double blind, placebo controlled trials. It has also been investigated as a treatment for spasticity due to multiple sclerosis and spinal cord injury. Arbaclofen was investigated as a treatment for gastroesophageal reflux disease (GERD); however, with disappointing results.

(-)-Baclofen Basic Attributes

213.66

213.66

NYU6UTW25B

DTXSID90219366

Characteristics

63.3

-1

1.3±0.1 g/cm3

188-189 °C @ Solvent: Hexane, Isopropanol

364.3°C at 760 mmHg

174.1±25.1 °C

1.577

2090

Store at RT

Safety Information

6.1

2811

DA8339450

P261, P264, P270, P271, P272, P280, P285, P301+P310, P302+P352, P304+P340, P304+P341, P305+P351+P338, P312, P321, P330, P332+P313, P333+P313, P337+P313, P342+P311, P362, P363, P403+P233, P405, P501

H300

|Danger|H300 (33.33%): Fatal if swallowed [Danger Acute toxicity, oral]|P261, P264, P270, P271, P272, P280, P285, P301+P310, P302+P352, P304+P340, P304+P341, P305+P351+P338, P312, P321, P330, P332+P313, P333+P313, P337+P313, P342+P311, P362, P363, P403+P233, P405, and P501|Aggregated GHS information provided by 3 companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Drug Information

Investigated in clinical trials as a potential treatment for spasticity in multiple sclerosis, autism spectrum disorder, and social withdrawal in fragile X syndrome.

Unlike baclofen, absorption of arbaclofen is not limited to the upper small intestine. Arbaclofen can also be absorbed in the lower small intestine and the colon, allowing for the development of sustained release formulations.|>80% of R-baclofen is renally eliminated unchanged.|Blood clearance of an IV bolus of R-baclofen in rats, monkeys, and dogs, resulted in a half life of 1.6-3.4hours, in one study. Total blood clearance was reported to be 0.51±0.13L/h/kg in rats, 0.31±0.11L/h/kg in monkeys, and 0.24±0.01L/h/kg in dogs. (2)

Arbaclofen, or R-baclofen, acts upstream of the mGluR5 receptor to increase inhibitory neurotransmission. It is the isomer of baclofen which harbors antispastic activity.

(-)-Baclofen Use and Manufacturing

Uses

R-Enantiomer of Baclofen. Specific GABA-B receptor agonist. Muscle relaxant (skeletal).

Human drugs -> Rare disease (orphan)

Computed Properties

Molecular Weight:213.66
XLogP3:-1
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:3
Rotatable Bond Count:4
Exact Mass:213.0556563
Monoisotopic Mass:213.0556563
Topological Polar Surface Area:63.3
Heavy Atom Count:14
Complexity:191
Defined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of (-)-Baclofen

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.